IFN-free Combination Therapy in HCV-infected Patients Treatment-naive:HCVerso1
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to confirm efficacy of treatment for 16 and 24 weeks in chronically
infected HCV GT1b treatment naïve patients, including patients with compensated cirrhosis.